Review article · 2022 · Open access
PROTAC targeted protein degraders: the past is prologue
Nature Reviews Drug Discovery, 21(3), 181–200 · Published 18 January 2022 · DOI 10.1038/s41573-021-00371-6
In brief
“PROTAC targeted protein degraders: the past is prologue” is a 2022 review article by Miklós Békés and 2 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 3,712 citations as of 21 November 2026. It is open access: the full text is free to read at Nature Reviews Drug Discovery.
- Citations
- 3,712
- Most cited in
- 2026 (1,078)
- Field-weighted impact
- 64.50
- References
- 254
- Authors
- 3
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Békés, M., Langley, D. R., & Crews, C. M. (2022). PROTAC targeted protein degraders: the past is prologue. Nature Reviews Drug Discovery, 21(3), 181–200. https://doi.org/10.1038/s41573-021-00371-6
MLA 9
Békés, Miklós, et al. “PROTAC targeted protein degraders: the past is prologue.” Nature Reviews Drug Discovery, vol. 21, no. 3, 2022, pp. 181–200. https://doi.org/10.1038/s41573-021-00371-6.
Chicago
Békés, Miklós, David R. Langley, and Craig M. Crews. 2022. “PROTAC targeted protein degraders: the past is prologue.” Nature Reviews Drug Discovery 21 (3): 181–200. https://doi.org/10.1038/s41573-021-00371-6.
Harvard
Békés, M., Langley, D. R. and Crews, C. M. (2022) ‘PROTAC targeted protein degraders: the past is prologue’, Nature Reviews Drug Discovery, 21(3), pp. 181–200. doi:10.1038/s41573-021-00371-6.
IEEE
M. Békés, D. R. Langley, and C. M. Crews, “PROTAC targeted protein degraders: the past is prologue,” Nature Reviews Drug Discovery, vol. 21, no. 3, pp. 181–200, 2022, doi: 10.1038/s41573-021-00371-6.
BibTeX
@article{bekes2022protac,
title = {{PROTAC targeted protein degraders: the past is prologue}},
author = {Békés, Miklós and Langley, David R. and Crews, Craig M.},
journal = {Nature Reviews Drug Discovery},
year = {2022},
volume = {21},
number = {3},
pages = {181--200},
doi = {10.1038/s41573-021-00371-6},
url = {https://doi.org/10.1038/s41573-021-00371-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2014 | 1 | |
| 2022 | 239 | |
| 2023 | 561 | |
| 2024 | 813 | |
| 2025 | 1,019 | |
| 2026 | 1,078 |
Its field-weighted citation impact is 64.50: it has been cited 64.50 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- targeted protein degradation
- ubiquitin-proteasome system
- ubiquitin ligase
- undruggable targets
- cancer therapeutics
- precision medicine
- drug discovery
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Békés, M., Langley, D. R., & Crews, C. M. (2022). PROTAC targeted protein degraders: the past is prologue. Nature Reviews Drug Discovery, 21(3), 181–200. https://doi.org/10.1038/s41573-021-00371-6
How many times has this paper been cited?
3,712 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature Reviews Drug Discovery: sign in and open the PDF from this page.
Who wrote this paper?
Miklós Békés, David R. Langley, Craig M. Crews.
What is the DOI of this paper?
10.1038/s41573-021-00371-6, permanently at https://doi.org/10.1038/s41573-021-00371-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.